Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study.
Geoffrey C Buckle, Alita Mrema, Michael Mwachiro...
https://pubmed.ncbi.nlm.nih.gov/35045815/Actively Recruiting
Led by University of California, San Francisco · Updated on 2026-07-22
2476
Participants Needed
6
Research Sites
N/A
Total Duration
Researchers are conducting a prospective observational study through the African Esophageal Cancer Consortium AfrECC to examine treatment outcomes for adults diagnosed with esophageal cancer. The study aims to describe various treatment methods used, assess patient experiences during and after treatment, and evaluate overall survival rates across participating sites. Participants in this study will receive standard treatments such as chemotherapy, radiation, chemo-radiotherapy, esophageal stenting, surgery, or supportive care as determined by their healthcare providers. The research involves collecting data from medical records and administering questionnaires to capture patient-reported outcomes related to these treatments over up to four years. During the study, participants will complete questionnaires, and their medical charts will be reviewed to gather information on treatment types and patient experiences. Researchers will measure the proportion of participants receiving different treatments, track changes in patient-reported symptom scores over time, and monitor overall survival. The study is planned to continue through June 2027, supporting long-term evaluation of treatment effects and patient quality of life.
CONDITIONS
Treatment Outcomes of Esophageal Cancer
G
Geoffrey Buckle, MD, MPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of California, San Francisco
Lead Sponsor
Westat
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 4 years
Participants complete questionnaires about their treatment experiences while researchers collect data from medical records to evaluate treatments and patient outcomes over time.
Periodic questionnaire and medical record reviews
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Geoffrey C Buckle, Alita Mrema, Michael Mwachiro...
https://pubmed.ncbi.nlm.nih.gov/35045815/Gift Mulima, Gita N Mody, Bongani Kaimila...
https://pubmed.ncbi.nlm.nih.gov/41232057/University of California, San Francisco
Lead Sponsor
Westat
Collaborating Sponsor